Peripheral Arterial DiseaseHemodialysisBackground: Peripheral arterial disease (PAD) is common in patients with chronic kidney disease (CKD). It is a surrogate marker of generalized atherosclerosis. In sub-Saharan Africa, PAD remains understudied in CKD. Ankle-brachial index (ABI) is a non-invasive...
patient‐centred outcomesperipheral arterial diseasetreatmentPeripheral arterial disease (PAD) impairs patients' quality of life (QOL), walking and ulcer healing, increasing patient pain, costs, and risks of amputation or mortality. A literature appraisal described PAD treatment capacity to improve ...
develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease ...
Peripheral arterial disease – still on the periphery? Editor – Changes to the UK’s General Medical Services (GMS) quality and outcomes framework review were announced in the New Year and include a number of new therapeutic areas. However, although the GMS contract continues to emphasise risk ...
Alteplase: Peripheral arterial embolism in an elderly patient: case report
Background: Hypertension is major risk-factor for Peripheral Arterial Disease (PAD). We prospectively assessed the prevalence of undertreated hypertension in patients presenting with PAD across a region in the UK and estimated its impact on presentation and outcome. Methods: We prospectively assessed ...
The trial found that rivaroxaban (Xarelto; Janssen Pharmaceutical Companies) at a vascular dose of 2.5 mg twice daily plus aspirin 100 mg once daily lowers severe vascular events in patients with peripheral arterial disease (PAD) following lower-extremity revascularization. These findings, highlight ...
Symptomatic and asymptomatic peripheral arterial occlusive disease (PAD) is indicative of widespread atherosclerosis. The major threat is from cardiovascular ischaemic events; thus, an important therapeutic goal is to modify atherosclerotic risk factors. Data from several large drug trials indicate that pat...
Patient predictors of arterial calcification8 Diabetes Chronic Kidney Disease Advanced Age (>65 y/o) Smoker Dyslipidemia Hypertension Prior CABG Known PAD/CAD Challenges associated with calcium8,9,10 Decreased balloon and stent success Associated with a higher procedural complication rate that may be a...
News of a PAD diagnosis can be an emotional experience. The condition may require medication or endovascular treatment to keep the disease from progressing.